Skip to main content
Clinical Trials/NCT00794066
NCT00794066
Completed
Not Applicable

Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients

University of Erlangen-Nürnberg Medical School1 site in 1 country1,500 target enrollmentAugust 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Artery Disease
Sponsor
University of Erlangen-Nürnberg Medical School
Enrollment
1500
Locations
1
Primary Endpoint
Functional outcome (modified Rankin Scale)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Purpose:

To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

Interventions:

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Design:

Prospective, open, cohort study.

Study size planned:

Follow-up duration:

3 months.

Registry
clinicaltrials.gov
Start Date
August 2008
End Date
October 23, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All consecutive adult patients with acute ischemic or hemorrhagic stroke.

Exclusion Criteria

  • Congestive heart failure.

Outcomes

Primary Outcomes

Functional outcome (modified Rankin Scale)

Time Frame: 3 months

Secondary Outcomes

  • Prevalence of peripheral arterial disease(during hospital stay)

Study Sites (1)

Loading locations...

Similar Trials